INmune Bio Inc.

8.11
0.52 (6.85%)
At close: Apr 02, 2025, 3:59 PM
7.94
-2.10%
After-hours: Apr 02, 2025, 07:55 PM EDT

INmune Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 14K 155K 374K 181K 10.92K 77.69M n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 14K 155K 374K 181K 10.92K 77.69M n/a n/a n/a n/a
Operating Income -42.63M -29.74M -25.95M -29.15M -12.23M -7.76M -12.44M -981.48K -227.49K -48.87K
Interest Income n/a n/a n/a n/a n/a 77.69K n/a n/a n/a n/a
Pretax Income -42.08M -30.01M -27.3M -30.34M -12.1M -7.68M -12.44M -831.49K -277.49K -48.87K
Net Income -42.08M -30.01M -28.65M -30.34M -12.1M -9.14M -12.44M -831.49K -277.49K -48.87K
Selling & General & Admin 9.48M 9.62M 9.26M 8.79M 6.32M 6.02M 11.33M 546.12K 126K 48.87K
Research & Development 33.17M 20.27M 17.07M 20.54M 5.92M 3.28M 1.11M 435.36K 101.5K n/a
Other Expenses n/a n/a -1.35M -1.19M 128.52K n/a n/a -6 n/a n/a
Operating Expenses 42.65M 29.9M 26.32M 29.33M 12.24M 9.3M 12.44M 981.48K 227.49K 48.87K
Interest Expense n/a n/a 1.35M n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a -146.6K
Cost & Expenses 42.65M 29.9M 26.32M 29.33M 12.24M 9.3M 12.44M 981.48K 227.49K 48.87K
Income Tax n/a n/a 1.35M -29.15M -12.23M 1.46M -161.14K -1.13M -177.49K n/a
Shares Outstanding (Basic) 20.19M 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
Shares Outstanding (Diluted) 20.19M 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
EPS (Basic) -2.08 -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EPS (Diluted) -2.08 -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EBITDA -42.63M -29.74M n/a n/a n/a n/a n/a 149.99K -50K 146.6K
EBIT -42.63M -29.74M -25.95M -29.15M -12.23M -7.68M -12.44M -831.49K -277.49K -48.87K
Depreciation & Amortization n/a n/a 25.95M 29.15M 12.23M 9.3M 12.44M 981.48K 227.49K 195.47K